Alkem Laboratories Ltd 24 Jan 2026 12:00 AM
Alkem Laboratories to table results,
Alkem Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News
Alkem Laboratories Ltd 08 Jan 2026 12:00 AM
Alkem launches Renocia cyclical therapy kit for hair care,
Alkem Laboratories announced the launch of Renocia cyclical therapy kit, a scientifically-designed weekly nutritional supplementation regimen to support hair growth, strengthen hair follicles and manage hair loss. The supplements in the kit are made using only vegetarian-sourced ingredients. Renocia cyclical therapy kit contains a set of nutritional supplements, including vitamins, minerals, and amino acids, each to be taken on designated days of the week. This structured weekly protocol enables better nutrient absorption and utilisation. Alkem has a growing portfolio of products in the dermatology segment, which includes skin and hair care. Under the Renocia brand, the company offers several products for hair care such as hair revitalizing shampoo, conditioner and serum, as well as oral supplements. Powered by Capital Market - Live News
Alkem Laboratories Ltd 08 Dec 2025 12:00 AM
Alkem Laboratories announces resignation of senior management personnel,
Alkem Laboratories announced that Rakesh Tripathi, a Senior Management Personnel has tendered his resignation from the services of the Company on account of personal commitments effective from 08 December 2025.Powered by Capital Market - Live News
Alkem Laboratories Ltd 05 Dec 2025 12:00 AM
Alkem Laboratories announces appointment of senior management personnel,
Alkem Laboratories announced that Prakash Ramnani has been appointed at senior management position in the Company effective from 05 December 2025.Powered by Capital Market - Live News
Alkem Laboratories Ltd 13 Nov 2025 12:00 AM
Alkem Laboratories consolidated net profit rises 11.10% in the September 2025 quarter,
Net profit of Alkem Laboratories rose 11.10% to Rs 765.06 crore in the quarter ended September 2025 as against Rs 688.64 crore during the previous quarter ended September 2024. Sales rose 17.17% to Rs 4000.99 crore in the quarter ended September 2025 as against Rs 3414.67 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales4000.993414.67 17 OPM %23.0122.05 - PBDT989.44859.17 15 PBT895.83780.26 15 NP765.06688.64 11 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now